Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bafetinib may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth.
PURPOSE: This clinical trial studies bafetinib in treating patients with recurrent high-grade
glioma or brain metastases.